益生菌在大腸激躁症治療上的角色

10.6666/ClinMed.202001_85(1).0007

黃任嫻

大腸激躁症（irritable bowel disease） ； 益生菌（probiotics）

臨床醫學月刊

85卷1期（2020 / 01 / 31）

32 - 35

繁體中文

大腸激躁症（irritable bowel syndrome, IBS）是一種腸胃道的功能障礙疾病，患者常會有不明原因的慢性腹痛及排便習慣改變，如腹瀉與便祕。不過，只有小部分的病人的症狀會需要到使用藥物治療的程度。而近來探討服用益生菌治療腸胃道疾病的研究日益增多，本篇即整理現有的大腸激躁症病患使用益生菌的對照實驗結果，總結來說，對於益生菌是否可以改善或治療大腸激躁症，仍沒有一個有力的實驗證據，也許部分該歸因於大腸激躁症在臨床表現上，本就在個體間具有很大的差異性。所以，要能證實益生菌是否具有治療大腸激躁症的療效，目前仍需要進一步的研究。

1. Brenner, DM,Moeller, MJ,Chey, WD(2009).The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review.Am J Gastroenterol,104,1033-1049.
2. Camilleri, M(2008).Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy.J Clin Gastroenterol,42,S123-S125.
3. Carroll, IM,Ringel-Kulka, T,Keku, TO(2011).Molecular analysis of the luminal- and mucosalassociated intestinal microbiota in diarrheapredominant irritable bowel syndrome.Am J Physiol Gastrointest Liver Physiol,301,G799-G807.
4. Chey, WD(2017).An EvidenceBased Approach to IBS and CIC: Applying New Advances to Daily Practice: A Review of an Adjunct Clinical Symposium of the American College of Gastroenterology Meeting October 16, 2016 * Las Vegas, Nevada.Gastroenterol Hepatol,13,1-16.
5. Drossman, DA,Li, Z,Andruzzi, E(1993).S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact.Dig Dis Sci,38,1569-1580.
6. Everhart, JE,Renault, PF(1991).Irritable bowel syndrome in office-based practice in the United States.Gastroenterology,100,998-1005.
7. Francavilla, R,Miniello, V,Magista, AM(2010).A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain.Pediatrics,126,1445-1452.
8. Giannetti, E,Maglione, M,Alessandrella, A(2017).A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.J Clin Gastroenterol,51,e5-e10.
9. Guglielmetti, S, MD,Gschwender, M,Popp, K(2011).Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.Aliment Pharmacol Ther,33,1123-1132.
10. Heaton, KW,O'Donnell, LJ,Braddon, FE(1992).Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters.Gastroenterology,102,1962-1967.
11. Jones, R,Lydeard, S(1992).Irritable bowel syndrome in the general population.BMJ,304,87-90.
12. Ki, Cha, B,Mun, Jung, S,Hwan, Choi, C(2012).The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrheadominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.J Clin Gastroenterol,46,220-227.
13. Lyra, A,Hillila, M,Huttunen, T(2016).Irritable bowel syndrome symptom severity improves equally with probiotic and placebo.World J Gastroenterol,22,10631-10642.
14. McFarland, LV,Dublin, S(2008).Meta-analysis of probiotics for the treatment of irritable bowel syndrome.World J Gastroenterol,14,2650-2661.
15. Moayyedi, P,Ford, AC,Talley, NJ(2010).The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review.Gut,59,325-332.
16. Nobaek, S,Johansson, ML,Molin, G(2000).Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome.Am J Gastroenterol,95,1231-1238.
17. O'Mahony, LMcCarthy, J,Kelly, P(2005).Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles.Gastroenterology,128,541-551.
18. O'Sullivan, MA,O'Morain, CA(2000).Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study.Dig Liver Dis,32,294-301.
19. Ringel, Y,Carroll, IM(2009).Alterations in the intestinal microbiota and functional bowel symptoms.Gastrointest Endosc Clin N Am,19,141-150.
20. Saggioro, A(2004).Probiotics in the treatment of irritable bowel syndrome.J Clin Gastroenterol,38,S104-S106.
21. Sayuk, GS,Wolf, R,Chang, L(2017).Comparison of Symptoms, Healthcare Utilization, and Treatment in Diagnosed and Undiagnosed Individuals With Diarrhea-Predominant Irritable Bowel Syndrome.Am J Gastroenterol,112,892-899.
22. Sen, S,Mullan, MM,Parker, TJ(2002).Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome.Dig Dis Sci,47,2615-2620.
23. Sisson, G,Ayis, S,Sherwood, RA(2014).Randomised clinical trial: A liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind study.Aliment Pharmacol Ther,40,51-62.
24. Staudacher, HM,Lomer, MCE,Farquharson, FM(2017).A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.Gastroenterology,153,936-947.
25. Stevenson, C,Blaauw, R,Fredericks, E(2014).Randomized clinical trial: effect of Lactobacillus plantarum 299 v on symptoms of irritable bowel syndrome.Nutrition,30,1151-1157.
26. Talley, NJ,Zinsmeister, AR,Van, Dyke, C(1991).Epidemiology of colonic symptoms and the irritable bowel syndrome.Gastroenterology,101,927-934.
27. Whelan, K,Quigley, EM(2013).Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease.Curr Opin Gastroenterol,29,184-189.
28. Whorwell, PJ,Altringer, L,Morel, J(2006).Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome.Am J Gastroenterol,101,1581-1590.